Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review.AIDS research and therapy · 2017
   Pooled it
2. High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.PloS one · 2014
   Trial
3. High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study.Medicine · 2017
   Article
4. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.BMC infectious diseases · 2016
   Observational
5. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.AIDS (London, England) · 2014
   Article
6. Short communication: prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients.AIDS research and human retroviruses · 2014
   Article
7. Clinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients.PloS one · 2014
   Article
8. Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe.BioMed research international · 2014
   Article
9. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.BMC infectious diseases · 2013
   Article
10. Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?The Indian journal of medical research · 2011
    Review
11. Treatment switching in South Indian patients on HAART: what are the predictors and consequences?AIDS care · 2011
    Article
12. Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2011
    Article
13. Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting.Journal of the International AIDS Society · 2010
    Article

Corrections and comments

• Comment on
  Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.2009

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as